Paper23908470
Biomarkers for prediction of venous thromboembolism in cancer.
Pabinger I and 2 others. Blood, 2013. Cited by 202 papers, by iCite.
Cite this record
ConductScience Library. Biomarkers for prediction of venous thromboembolism in cancer. Papers, record 23908470. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23908470
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Venous Thromboembolism | Major topic |
| Biomarkers | |
| Blood Coagulation | |
| Humans | |
| Prognosis |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03646409 | Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer | Background |
Source ClinicalTrials.gov
Cited by120
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 202 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42780610 | Elevated D-dimer levels in high-risk multiple myeloma patients: a systematic review and meta-analysis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42780610 | PubMed |
| 42645093 | Systemic Immune-Inflammation Index, Thrombotic Status, and Mortality in Patients with Cancer: A Matched Cohort Study. | Diseases | 2026 | https://conductscience.org/library/papers/42645093 | PubMed |
| 42355911 | Persistent Hypercoagulability After Radical Prostatectomy: Biomarker Dynamics and Implications for Individualized Thromboprophylaxis. | J Clin Med | 2026 | https://conductscience.org/library/papers/42355911 | PubMed |
| 42353272 | An Immunothrombotic Extracellular Vesicle mRNA Profile Associated with Thrombosis in Lung Adenocarcinoma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353272 | PubMed |
| 42149309 | External validation of established clinical risk scores for cancer-associated venous thromboembolism in a Brazilian registry. | J Thromb Thrombolysis | 2026 | https://conductscience.org/library/papers/42149309 | PubMed |
| 42149304 | Platelet FcɣRIIa: a novel biomarker of risk for thromboembolism and death in cancer. | J Thromb Thrombolysis | 2026 | https://conductscience.org/library/papers/42149304 | PubMed |
| 41873098 | Thromboembolic Risks in Pancreatic Ductal Adenocarcinoma: A Review of Anatomical and Clinical Variations. | Can J Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/41873098 | PubMed |
| 41643195 | NXTAGE: a phase 1/2 study of NXT007 to assess safety, pharmacokinetics, and efficacy in hemophilia A without inhibitors. | Blood | 2026 | https://conductscience.org/library/papers/41643195 | PubMed |
| 41638873 | Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41638873 | PubMed |
| 41586909 | Global research status and trends in venous thromboembolism and pancreatic cancer: a bibliometric analysis. | Support Care Cancer | 2026 | https://conductscience.org/library/papers/41586909 | PubMed |
| 41510706 | Circulating tumor cells and circulating tumor microemboli: role in venous thromboembolism in oncologic patients. | Biosci Rep | 2026 | https://conductscience.org/library/papers/41510706 | PubMed |
| 41406072 | Predictive Value of RDW and RCI Indices in Pulmonary Embolism: Insights from Breast Cancer, Lung Cancer, and Non-Cancer Patients. | Clin Appl Thromb Hemost | 2025 | https://conductscience.org/library/papers/41406072 | PubMed |
| 41249955 | Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41249955 | PubMed |
| 41156207 | Pulmonary Embolism in Hematologic Malignancies: Predictive Value of the D-Dimer/Albumin Ratio and Proposal of the Hema-PE Score. | J Clin Med | 2025 | https://conductscience.org/library/papers/41156207 | PubMed |
| 40874223 | Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort study. | Front Oncol | 2025 | https://conductscience.org/library/papers/40874223 | PubMed |
| 39846434 | Assessing the Comparative Efficacy and Safety of Warfarin and Rivaroxaban for Cancer Associated Thrombosis: Experience From a Resource Limited Setting. | Cancer Rep (Hoboken) | 2025 | https://conductscience.org/library/papers/39846434 | PubMed |
| 39635429 | Machine learning models can predict cancer-associated disseminated intravascular coagulation in critically ill colorectal cancer patients. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39635429 | PubMed |
| 39262796 | Blood cell traits and venous thromboembolism in East Asians: Observational and genetic evidence. | iScience | 2024 | https://conductscience.org/library/papers/39262796 | PubMed |
| 38893201 | Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38893201 | PubMed |
| 38676874 | Comprehensive evaluation of genetic and acquired thrombophilia markers for an individualized prediction of clinical thrombosis in patients with lymphoma and multiple myeloma. | J Thromb Thrombolysis | 2024 | https://conductscience.org/library/papers/38676874 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| SELP | 6403 | PubTator's text mining | https://conductscience.org/library/genes/6403 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23908470
GET https://conductscience.org/api/papers/v1/23908470/cited_by?page=2